The Paul, Weiss Litigation Department is led by a team of the country’s most accomplished trial lawyers. Our litigators in New York, San Francisco and Washington, D.C. handle the most complex and demanding lawsuits, class actions, government investigations, criminal prosecutions and restructurings. Our clients include Fortune 50 corporations and other prominent companies in the financial services, investment, medical device, pharmaceutical, sports, technology, energy, media and insurance industries. Every day, we are called on by chief executives, board chairs, general counsel, investors and entrepreneurs for our unmatched trial skills, sophisticated business judgment and renowned strategic advice.
United States Supreme Court Limits Investor Suits for Misleading Statements of Opinion
March 25, 2015 download PDF
The United States Supreme Court issued a decision yesterday that
resolves a split in the federal courts of appeals regarding when
statements of opinion may give rise to liability under the federal
securities laws. In Omnicare, Inc. v. Laborers'
District Council Construction Industry Pension Fund, No.
13-435, the Supreme Court addressed the pleading standard for
claims alleging a false or misleading opinion in an issuer's
registration statement under Section 11 of the Securities
Act. The Court voted 9-0 to vacate a decision by the Sixth
Circuit Court of Appeals which had held that issuers and
individuals who sign a registration statement may be held liable
for statements of opinion that later turn out to be false,
regardless of their subjective belief in those statements.
In rejecting the Sixth Circuit's conclusion, the Supreme Court
emphasized that the federal securities laws do not create liability
based merely on a statement of belief that "turned out to be
wrong." Rather, the Court held, a statement of opinion is
actionable under Section 11 as an "untrue statement of material
fact" only if the speaker did not honestly hold the opinion when it
was expressed. The Court also held that, in certain
circumstances, statements of opinion may be actionable based on an
omission of material fact that renders the statements misleading to
a reasonable investor.
The Omnicare decision may help to limit the scope of
liability faced by companies, as well as their officers and
directors, for alleged misstatements of opinion. But the
decision also leaves significant uncertainty as to the
circumstances under which affirmative statements of opinion will
give rise to omission claims.
Background
In December 2005, Omnicare, a leading provider of pharmacy
services for residential nursing homes, filed a registration
statement in connection with a public offering of common
stock. The registration statement included two statements
expressing the Company's opinion that its contracts with
pharmaceutical manufacturers complied with federal and state
laws. The federal government subsequently sued Omnicare for
allegedly receiving kickbacks, in the form of improper rebates,
from pharmaceutical manufacturers. Pension funds that had
purchased Omnicare stock in the public offering (the "Funds") in
turn filed suit against the Company for violating Section 11.
The Funds alleged that Omnicare's opinion statements concerning the
legality of its contracts were materially false because none of the
Company's officers and directors "possessed reasonable grounds" to
express those opinions, given the kickbacks and other illicit
activities brought to light by the government's case.
In February 2012, the United States District Court for the Eastern
District of Kentucky granted Omnicare's motion to dismiss the
Funds' complaint on the ground that "statements regarding a
company's belief as to its legal compliance" are actionable only if
those who made them "knew [they] were untrue at the time." In
this regard, the District Court followed the decision of
the United States Court of Appeals for the Second
Circuit in Fait v. Regions Financial Corp., which
held that to state a claim under Section 11 based on a statement of
opinion, plaintiffs must allege that the statement was both
objectively false (i.e., it turned out to be incorrect)
and subjectively false (i.e., the speaker did not genuinely believe
the opinion at the time the statement was made). 655 F.3d
105, 112 (2d Cir. 2011); see also Rubke v. Capitol
Bancorp Ltd., 551 F.3d 1156, 1162 (9th Cir. 2009) (fairness
opinions "can give rise to a claim under [S]ection 11 only if the
complaint alleges with particularity that the statements were both
objectively and subjectively false and misleading"). The
District Court found that the Funds could not meet that standard
because they failed to allege that Omnicare's officers and
directors knew they were violating the anti-kickback laws at the
time the challenged opinion statements were made.
The Court of Appeals for the Sixth Circuit reversed. The
Court of Appeals acknowledged that Omnicare's statements expressed
opinions, rather than facts. It held, however, that the
Funds' allegation that the statements were objectively false was
sufficient to state a claim under Section 11, regardless of the
Omnicare officers' subjective belief in their opinions at the time
they were expressed.
In reaching this conclusion, the Sixth Circuit expressly disagreed
with the holdings of Fait and Rubke, thereby
creating a circuit split on the issue of whether, under Section 11,
a plaintiff may plead that a statement of opinion was "untrue"
merely by alleging that the opinion was objectively
incorrect. The Supreme Court granted certiorari in
Omnicare to address that question.
The Supreme Court Majority Opinion
In an opinion by Justice Kagan, the Supreme Court vacated the
Sixth Circuit's decision. Unlike the Court of Appeals, the
Supreme Court analyzed the question of Section 11 liability in two
steps-first addressing whether Omnicare's opinion statements could
be held to constitute affirmative misstatements of fact, and second
addressing whether those statements could give rise to liability
based on an "omissions" theory.
The Supreme Court began its analysis by distinguishing statements
of fact, which express "certainty about a thing," from statements
of opinion, which do not. (Slip op. at 6.) Applying
this distinction to Omnicare's statements that it "believe[d]" its
contracts with pharmaceutical manufacturers to be in compliance
with applicable laws, the Court concluded that such statements
expressed only opinions, not facts.
Such "pure statements of opinion," the Court held, could give rise
to liability under Section 11's false-statement provision only
where the speaker did not honestly hold the opinions being
expressed. (Id. at 9.) In this regard, the
Supreme Court agreed with the standards set forth in the Second
Circuit's Fait decision (though the Court did not address Fait
directly). Because the plaintiffs in Omnicare did
"not contest that Omnicare's opinion was honestly held," their
claims that the Company's opinion statements amounted to untrue
statements of fact failed.
The Court then considered when, if ever, the omission of a
material fact can render a statement of opinion misleading under
Section 11. Drawing on principles based in tort law, the
Court reasoned that issuers may be liable for material omissions
from statements of opinion in certain circumstances because a
reasonable investor might understand such statements to convey an
implied assertion that the speaker knows of facts "sufficient to
justify" the opinion being expressed. (Id. at
14.) Thus, the Court held that if a registration statement
omits material facts about the issuer's inquiry into or knowledge
concerning a statement of opinion, and if those facts conflict with
what a "reasonable investor" would take from the statement, the
omission may give rise to Section 11 liability. (Id.
at 12.)
Because the court below had not addressed the question of whether
the Omnicare plaintiffs' allegations were sufficient to satisfy
this standard, the Supreme Court remanded for further
proceedings.
Concurring Opinions
In an opinion concurring in part and concurring in the judgment,
Justice Scalia agreed with the Court's holding as to alleged
misstatements under Section 11's first provision. (Scalia
Concurrence at 1.) However, he advocated for a significantly
narrower understanding of when statements of opinion may be
considered misleading due to the omission of material facts.
In his view, Section 11 should give rise to liability for omissions
from statements of opinion only when the speaker subjectively
believes he lacks a reasonable basis for the statement.
(Id. at 6.) Justice Scalia observed that such an
inference would be unwarranted in Omnicare, where corporate
management simply opined on the Company's compliance with the law,
an area in which management concededly is not expert.
(Id. at 3.)
By adopting a test that requires consideration of what a
"reasonable investor"-as opposed to the speaker himself-would
consider a sufficient basis for a statement of opinion, Justice
Scalia predicted that the Court's decision will lead to "roundabout
attacks upon expressions of opinion" by investors "seeking
recompense for a corporation's expression of belief that turned
out, after the fact, to be incorrect." (Id. at
6-7.)
Justice Thomas separately filed a short opinion concurring in the
judgment only. He argued that the Court was right to vacate
the Sixth Circuit's decision, but that it should not have addressed
the issue of whether Omnicare omitted a material fact necessary to
make its statements not misleading because that question was not
addressed by the courts below.
Implications of the Decision
With all nine justices voting to vacate the Sixth Circuit's
decision, Omnicare provides a clear, if somewhat narrow,
limitation on the scope of Section 11 liability for statements of
opinion. The decision also leaves open a number of questions
that will require further development in the lower courts.
First, the Supreme Court's ruling underscores the
significance of distinguishing between statements of opinion and
statements of fact in the context of Section 11 claims and,
potentially, other types of claims under the federal securities
laws. Among other things, the decision confirms that whether
a statement is considered one of fact or opinion may be dispositive
of claims under Section 11 when the plaintiff has not alleged that
the speaker disbelieved the statement at the time it was
made.
The Omnicare opinion does not provide any bright-line
rule as to how to draw this distinction. The opinion does
strongly suggest that the presence of words like "I believe" may
indicate a statement of opinion, rather than one of fact, because
they can, in themselves, signal the speaker's uncertainty about a
statement and indicate the possibility that an opinion may later
turn out to be erroneous. (Id. at 7.) As a
result, issuers may be more likely-and well advised-to use such
"opinion" language in their registration statements and other
disclosures going forward. The Court's ruling, however, also
leaves considerable room for lower courts to develop more precise
rules about what types of statements do and do not constitute
opinions. It held that the inclusion of phrases such as "we
believe" or "we think" does not automatically make the statement
that follows one of opinion. (Id. at 16.) And
conversely, lower courts have held that statements unaccompanied by
these phrases may constitute statements of opinion. (1)
Second, the Supreme Court's ruling that a statement of
opinion may be actionable under Section 11 under an omissions
theory is likely open to a new avenue of litigation. Plaintiffs who
cannot allege that an opinion was not honestly held may instead
allege that it was based on inadequate inquiry or that there was
contrary information available to the speaker. The extent to
which such allegations are sufficient to avoid a motion to dismiss
will require further judicial development.
The Supreme Court emphasized, for example, that not all contrary
facts need to be disclosed in connection with an opinion
statement. To the contrary, "[a]n opinion statement . . . is
not necessarily misleading when an issuer knows, but fails to
disclose, some fact cutting the other way. Reasonable
investors understand that opinions sometimes rest on a weighing of
competing facts; indeed, the presence of such facts is one reason
why an issuer may frame a statement as an opinion, thus conveying
uncertainty." (Id. at 13.) Thus, to state a
viable claim, an investor must identify "particular (and material)
facts going to the basis for the issuer's opinion-facts about the
inquiry the issuer did or did not conduct or the knowledge it did
or did not have-whose omission makes the opinion statement at issue
misleading to a reasonable person reading the statement fairly and
in context." (Id. at 18.) As the Supreme Court
observed, "[t]hat is no small task for an investor"-particularly on
a pre-discovery complaint. (Id.)
The Court also observed that "whether an omission makes an
expression of opinion misleading always depends on context."
(Id. at 14.) In this regard, lower courts weighing
Section 11 claims of material omissions will need to consider the
opinion statement and the alleged omission of fact "in light of all
its surrounding text, including hedges, disclaimers, and apparently
conflicting information." (Id.) Also relevant
are "the customs and practices of the relevant industry."
(Id.) Here, too, it will be up to lower courts to
develop case law distinguishing actionable omissions from
non-actionable ones, and those distinctions may depend on industry
practice and other factors that the Supreme Court's opinion
references but does not conclusively determine.
Moreover, given the Court's statement that "to avoid exposure for
omissions under §11, an issuer need only divulge an opinion's
basis, or else make clear the real tentativeness of its belief"
(Id. at 19), issuers will need to consider what additional
factual information-and what qualifying language-should accompany
the opinions they express in registration statements and other
disclosures. The Court's opinion does not specify the level
of factual detail necessary to "divulge an opinion's basis," nor
does it prescribe the content of the disclaimers that would be
sufficient to "make clear the real tentativeness" of an issuer's
belief.
Finally, the Supreme Court's opinion does not address the
application of the standards it sets forth to claims based on
statements of opinion that are asserted under provisions of the
federal securities laws other than Section 11. The Second
Circuit Court of Appeals, for example, has held that the same
standards for pleading an actionable misstatement of opinion that
apply under Section 11-including subjective falsity-also apply to
claims asserted under Section 10(b) (in addition to the other
distinctive elements of a Section 10(b) claim, such as
scienter). See City of Omaha v. CBS Corp.,
679 F.3d 64, 67-68 (2d Cir. 2012).
The Supreme Court's opinion in Omnicare appears to leave
such lower court decisions intact-at least insofar as they concern
alleged misstatements. But, to the extent that lower courts
have not drawn the same distinction as the Supreme Court did
between affirmative misstatements of opinion and statements of
opinion that omit material facts, the decision also raises certain
unanswered questions. These include, for example, whether
plaintiffs alleging that a statement of opinion is materially
misleading under Section 10(b) because the defendant omits that he
failed to conduct an investigation supporting his opinion would be
entitled to a presumption of reliance under Affiliated Ute
Citizens v. United States, 406 U.S. 128 (1972), or
whether such plaintiffs would be required to demonstrate reliance
through one of the means applicable to a claim of alleged
misrepresentation.
Conclusion
Omnicare resolves a significant split in the federal
courts of appeals regarding when a statement of opinion may give
rise to liability under Section 11 of the federal securities
laws. The Supreme Court's decision thus provides some measure
of clarity for issuers of publicly-traded securities regarding the
risks associated with expressing opinions in registration
statements as well as in other types of disclosures. The
decision also places important limits on investors' ability to
bring federal securities claims based on such opinion
statements. At the same time, Omnicare leaves open
several important questions for lower courts to determine.
The precise scope of potential liability for statements of opinion
under the securities laws will depend on how broadly or narrowly
the lower courts apply Omnicare's holdings.